Glenn S. Tatem
Corporate Officer/Principal presso Alison Raffaele Cosmetics, Inc.
Provenienza dei contatti di primo grado di Glenn S. Tatem
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Alison Raffaele Cosmetics, Inc.
 Alison Raffaele Cosmetics, Inc. Specialty StoresRetail Trade Alison Raffaele Cosmetics, Inc. manufactures cosmetics and facial makeup products. Its products include powder, lipstick, lip gloss and blush, tools, and brushes. The firm was founded by Alison Raffaele Tatem in 2000 and is headquartered in Cliffside Park, NJ.
1
| Private Company | Specialty Stores | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Glenn S. Tatem tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
I-Flow Corp.
 I-Flow Corp. Medical SpecialtiesHealth Technology I-Flow Corp. designs, develops and manufactures ambulatory drug delivery systems. Its products include portable infusion pumps, catheters and pain kits. The company was founded in 1985 and is headquartered in Lake Forest, CA. | Medical Specialties | Director/Board Member | |
International Opera Alliance
 International Opera Alliance Miscellaneous Commercial ServicesCommercial Services International Opera Alliance is an entertainment company focused on musical and arts activities. The company is headquartered in Fairfax, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Oncolyze, Inc.
 Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Biotechnology | Founder | |
Bryologyx, Inc.
 Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA. | Pharmaceuticals: Major | Founder | |
Hadean Ventures AS
 Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Investment Managers | Private Equity Investor | |
| MEDITE CANCER DIAGNOSTICS INC | Medical Specialties | Director/Board Member | |
| Higuchi Bioscience Center | Director/Board Member | ||
| Dalyda Finance LLC | Corporate Officer/Principal | ||
| NEUROTROPE, INC. | Pharmaceuticals: Major | Chairman | |
OHK Medical Devices, Inc.
 OHK Medical Devices, Inc. Medical SpecialtiesHealth Technology OHK Medical Devices, Inc. develops and manufactures self-contained, sterile, exsanguinating tourniquet products. Its products include hand and wrist, foot and ankle, upper extremity, lower extremity and pediatrics. The company was founded by Noam Gavriely in 1999 and is headquartered in Grandville, MI. | Medical Specialties | Director/Board Member | |
| Players Club | Corporate Officer/Principal | ||
| Combimatrix Molecular Diagnostics, Inc. | Director/Board Member | ||
| ORYX TECHNOLOGY CORP. | Electrical Products | Director/Board Member | |
Medisync Midwest LLC
 Medisync Midwest LLC Miscellaneous Commercial ServicesCommercial Services Medisync Midwest LLC provides consultation services. It offers practice management partnership, clinical research, volume to value planning, diagnostic assessments, and HCC program. The company is headquartered in Cincinnati, OH. | Miscellaneous Commercial Services | Director/Board Member | |
| Medezrin Ltd. | Director/Board Member | ||
| Baystar Biosciences | Director/Board Member | ||
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
| CONTRAFECT CORPORATION | Biotechnology | Founder | |
| Northlea Partners LLLP | Corporate Officer/Principal | ||
| UniMedica, Inc. | Chairman | ||
| University of Birmingham | College/University | Doctorate Degree | |
| International University of Health Sciences | College/University | Corporate Officer/Principal | |
| COMBIMATRIX CORP | Biotechnology | Director/Board Member | |
| MedVest, Inc. | Founder | ||
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Pharmaceuticals: Major | Director/Board Member | |
Pattern Pharma, Inc.
 Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 28 |
| Regno Unito | 3 |
| Norvegia | 2 |
| Saint Kitts e Nevis | 2 |
| Canada | 2 |
Settori
| Health Technology | 15 |
| Commercial Services | 4 |
| Finance | 4 |
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
Posizioni
| Director/Board Member | 22 |
| Corporate Officer/Principal | 6 |
| Independent Dir/Board Member | 5 |
| Founder | 4 |
| Chairman | 3 |
Contatti più connessi
| Insiders | |
|---|---|
| John H. Abeles | 33 |
- Borsa valori
- Insiders
- Glenn S. Tatem
- Connessioni Società
